I agree! There is a list of items I don't like about their PR work but, two items that are a real thorn for me are;
The way CBIS is dangling the biopsy report carrot out there until after the 10-Q. You know they are sitting on that to try to prop up the PPS after the sh.. hits the fan.
And then the other relates to PRs back in the end of October and again the first week of November bragged;
The Company has been receiving a constant flow of inquires via its website, emails, and telephone calls for cannabis-extract based medicines.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.